FR3392M - Dermatological medicinal product, in particular for the treatment of oozing eczema. - Google Patents
Dermatological medicinal product, in particular for the treatment of oozing eczema.Info
- Publication number
- FR3392M FR3392M FR939737A FR939737A FR3392M FR 3392 M FR3392 M FR 3392M FR 939737 A FR939737 A FR 939737A FR 939737 A FR939737 A FR 939737A FR 3392 M FR3392 M FR 3392M
- Authority
- FR
- France
- Prior art keywords
- oozing
- eczema
- treatment
- medicinal product
- dermatological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2689662 | 1962-06-30 | ||
JP1043163 | 1963-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR3392M true FR3392M (en) | 1965-06-28 |
Family
ID=26345696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR939737A Active FR3392M (en) | 1962-06-30 | 1963-06-28 | Dermatological medicinal product, in particular for the treatment of oozing eczema. |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3392M (en) |
GB (1) | GB1043041A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002679A1 (en) * | 1977-12-15 | 1979-07-11 | Bayer Ag | 1-Halo-1-propyn-3-ols, process for their preparation and their use as fungicides |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104710323B (en) * | 2013-12-11 | 2018-05-15 | 中国疾病预防控制中心寄生虫病预防控制所 | Salicylamide ester type compound and its preparation and use with ovicidal trait |
-
1963
- 1963-06-12 GB GB23325/63A patent/GB1043041A/en not_active Expired
- 1963-06-28 FR FR939737A patent/FR3392M/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002679A1 (en) * | 1977-12-15 | 1979-07-11 | Bayer Ag | 1-Halo-1-propyn-3-ols, process for their preparation and their use as fungicides |
Also Published As
Publication number | Publication date |
---|---|
GB1043041A (en) | 1966-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2427M (en) | Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders. | |
FR1593M (en) | Compositions for the treatment of acne. | |
FR3392M (en) | Dermatological medicinal product, in particular for the treatment of oozing eczema. | |
FR1438M (en) | New drug effective in the treatment of atherosclerosis. | |
FR126M (en) | New drug, in particular for the treatment of postprandial or chronic hyperlipemia. | |
FR3066M (en) | New drug, in particular for the treatment of postprandial or chronic hyperlipemia. | |
FR2576M (en) | New drug, in particular for the treatment of blood coagulability disorders. | |
FR3395M (en) | New drug, in particular for the treatment of neurodepressive states and anxiety psychoses. | |
FR1489M (en) | 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases. | |
FR1903M (en) | New medicament based on an ether which can be used, in particular for the treatment of various solid tumors. | |
FR1204M (en) | New drug, in particular for the treatment of chronic or post-prandial hyperlipemia. | |
FR2323M (en) | New drug, in particular for the treatment of follicle-stimulating hyperactivity. | |
FR1830M (en) | New drug in particular for the treatment of follicle-stimulating hyperactivity. | |
FR2413M (en) | New drug, in particular for the treatment of inflammatory and painful manifestations. | |
FR3881M (en) | Medicament useful in particular for the treatment of tuberculosis. | |
FR2014M (en) | Medicament for the treatment of eczema and other skin diseases, in particular conditions causing baldness. | |
FR1512M (en) | New drug in particular for the treatment of arterial hypertension. | |
FR1466M (en) | New drug in particular for the treatment of arterial hypertension. | |
FR1143M (en) | Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia. | |
FR3096M (en) | New drug in particular for the treatment of states of adynamia. | |
FR1122M (en) | New drug in particular for the treatment of hypercholesterolemia. | |
FR3526M (en) | Therapeutic composition for the treatment of acne. | |
BE598665A (en) | Pharmaceutical preparations for the treatment of leukemia. | |
FR2656M (en) | New drug, in particular for the treatment of chronic or postprandial hyperlipemia. | |
FR1329M (en) | Pharmaceutical compositions for the treatment of leprosy. |